Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 8.738.635.795.754.70

What is the latest EV/Core EBITDA ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of LINCOLN PHARMACEUTICALS is 8.73 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20258.73
Mar20248.63
Mar20235.79
Mar20225.75
Mar20214.70

How is EV/Core EBITDA of LINCOLN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 8.73
1.16
Mar2024 8.63
49.05
Mar2023 5.79
0.70
Mar2022 5.75
22.34
Mar2021 4.7 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,236.8 Cr 0.3% 34.1% 13.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,531.0 Cr 1.3% 8.9% 6% Stock Analytics
DIVIS LABORATORIES ₹169,989.0 Cr 2.4% 6% 12.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,936.0 Cr -0.6% 9.4% 44.1% Stock Analytics
CIPLA ₹109,200.0 Cr 1.9% 2% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹108,057.0 Cr -0.4% 9.5% 10.5% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

0.3%

34.1%

13.9%

SENSEX

-3.7%

-2.5%

6.5%


You may also like the below Video Courses